Results 161 to 170 of about 3,217 (228)

Phase I dose-escalation studies of roniciclib, a pan-cyclin-dependent kinase inhibitor, in advanced malignancies. [PDF]

open access: yesBr J Cancer, 2017
Bahleda R   +18 more
europepmc   +1 more source

Rationale and design of the German-Speaking Myeloma Multicenter Group (GMMG) trial ReLApsE: a randomized, open, multicenter phase III trial of lenalidomide/dexamethasone versus lenalidomide/dexamethasone plus subsequent autologous stem cell transplantation and lenalidomide maintenance in patients with relapsed multiple myeloma. [PDF]

open access: yesBMC Cancer, 2016
Baertsch MA   +28 more
europepmc   +1 more source

1,1,2,2-Tetra-kis(1,3-benzoxazol-2-yl)ethene. [PDF]

open access: yesActa Crystallogr Sect E Struct Rep Online, 2011
Hagos TK   +4 more
europepmc   +1 more source

Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region. [PDF]

open access: yesBMC Cancer, 2015
Berenstein R   +9 more
europepmc   +1 more source

Mechanisms governing bystander activation of T cells. [PDF]

open access: yesFront Immunol
Yosri M   +4 more
europepmc   +1 more source

1,1,2,2-Tetra-kis(1,3-benzothia-zol-2-yl)ethene chloro-form disolvate. [PDF]

open access: yesActa Crystallogr Sect E Struct Rep Online, 2010
Hagos TK   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy